Identification of environmental factors that promote intestinal inflammation
Genome-wide association studies have identified risk loci linked to inflammatory bowel disease (IBD) 1 —a complex chronic inflammatory disorder of the gastrointestinal tract. The increasing prevalence of IBD in industrialized countries and the augmented disease risk observed in migrants who move int...
Saved in:
Published in: | Nature (London) Vol. 611; no. 7937; pp. 801 - 809 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
Nature Publishing Group UK
24-11-2022
Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Genome-wide association studies have identified risk loci linked to inflammatory bowel disease (IBD)
1
—a complex chronic inflammatory disorder of the gastrointestinal tract. The increasing prevalence of IBD in industrialized countries and the augmented disease risk observed in migrants who move into areas of higher disease prevalence suggest that environmental factors are also important determinants of IBD susceptibility and severity
2
. However, the identification of environmental factors relevant to IBD and the mechanisms by which they influence disease has been hampered by the lack of platforms for their systematic investigation. Here we describe an integrated systems approach, combining publicly available databases, zebrafish chemical screens, machine learning and mouse preclinical models to identify environmental factors that control intestinal inflammation. This approach established that the herbicide propyzamide increases inflammation in the small and large intestine. Moreover, we show that an AHR–NF-κB–C/EBPβ signalling axis operates in T cells and dendritic cells to promote intestinal inflammation, and is targeted by propyzamide. In conclusion, we developed a pipeline for the identification of environmental factors and mechanisms of pathogenesis in IBD and, potentially, other inflammatory diseases.
The herbicide propyzamide increases inflammation in the small and large intestine, and the AHR–NF-κB–C/EBPβ signalling axis—which operates in T cells and dendritic cells to promote intestinal inflammation—is targeted by propyzamide. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions L.M.S., C.-C.C., J.E.K. and F.J.Q. designed research. L.M.S., C.-C.C., J.E.K., J.M.R., C.M.R.-G., C.M.P., C.G.-V., G.P., A.P., L.L., F.G., H.-G.L., C.F.A., M.A.W., I.M., M.J., M.A., P.H., A.Y., B.M.A., D.G.F., M.E., V.R., M.T., K.A.d.L., M.L., L.G., R.C., H.Q., P.H.F.-C. and M.A.B. performed experiments. L.M.S., C.-C.C., J.E.K., Z.L., E.C.T., V.R., L.M.C., K.J.H, M.E.H., J.K., R.H., S.B.S. and F.J.Q. analysed data. A.M. contributed mice and reagents. Y.-C.W., E.C.T. and C.-J.H. performed machine learning. L.M.S., C.-C.C., J.E.K. and F.J.Q. wrote the paper with input from all of the authors. F.J.Q. directed and supervised the study. |
ISSN: | 0028-0836 1476-4687 1476-4687 |
DOI: | 10.1038/s41586-022-05308-6 |